| Presented by: | The American College of Chest Physicians |
| Lecturer | Robert A. Sandhaus, MD, PhD, FCCP |
| Approximate duration: | Not available |
| Summary points: | This text-based CME activity describes the mechanisms of disease in alpha1-antitrypsin deficiency (AATD), reviews the obstacles in identifying individuals with AATD, recommends appropriate follow-up, and discusses the indications for augmentation therapy and its appropriate usage. |
| Accreditation: | The American College of Chest Physicians is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Chest Physicians designates this educational activity for a maximum of 24.0 AMA PRA Category 1 Credit(s).
Expiration date: December 31, 2011. |
| Other: | Text-only CME. |
E-Mail this webcast/CME to a colleague
Alpha1-Antitrypsin Augmentation: Approaches and Benefits
Go to webcast/CME
E-Mail this webcast/CME to a colleague
Remind me of this
